{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:31:30Z","timestamp":1790422290944,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972345"],"award-info":[{"award-number":["81972345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor for which new therapeutic approaches are urgently required. Unfolded protein response (UPR) plays an important role in the progression of GBM and is a promising target for developing novel therapeutic interventions. We identified ubiquitin-activating enzyme 1 (UBA1) inhibitor TAK-243 that can strongly induce UPR in GBM cells. In this study, we evaluated the functional activity and mechanism of TAK-243 in preclinical models of GBM. TAK-243 significantly inhibited the survival, proliferation, and colony formation of GBM cell lines and primary GBM cells. It also revealed a significant anti-tumor effect on a GBM PDX animal model and prolonged the survival time of tumor-bearing mice. Notably, TAK-243 more effectively inhibited the survival and self-renewal ability of glioblastoma stem cells (GSCs) than GBM cells. Importantly, we found that the expression level of GRP78 is a key factor in determining the sensitivity of differentiated GBM cells or GSCs to TAK-243. Mechanistically, UBA1 inhibition disrupts global protein ubiquitination in GBM cells, thereby inducing ER stress and UPR. UPR activates the PERK\/ATF4 and IRE1\u03b1\/XBP signaling axes. These findings indicate that UBA1 inhibition could be an attractive strategy that may be potentially used in the treatment of patients with GBM, and GRP78 can be used as a molecular marker for personalized treatment by targeting UBA1.<\/jats:p>","DOI":"10.1038\/s41419-021-04023-w","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T07:04:18Z","timestamp":1627023858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["RETRACTED ARTICLE: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death"],"prefix":"10.1038","volume":"12","author":[{"given":"Guanzheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8039-4174","authenticated-orcid":false,"given":"Xuejiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"4023_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.canlet.2020.01.027","volume":"475","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wu W, Bi H, Yang D, Zhang C. Glioblastoma precision therapy: from the bench to the clinic. Cancer Lett. 2020;475:79\u201391.","journal-title":"Cancer Lett."},{"key":"4023_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature23000","volume":"547","author":"TE Miller","year":"2017","unstructured":"Miller TE, Liau BB, Wallace LC, Morton AR, Xie Q, Dixit D, et al. Transcription elongation factors represent in vivo cancer dependencies in glioblastoma. Nature. 2017;547:355\u20139.","journal-title":"Nature"},{"key":"4023_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.drup.2018.03.003","volume":"42","author":"F Sharifzad","year":"2019","unstructured":"Sharifzad F, Ghavami S, Verdi J, Mardpour S, Mollapour Sisakht M, Azizi Z, et al. Glioblastoma cancer stem cell biology: potential theranostic targets. Drug Resist Updat. 2019;42:35\u201345.","journal-title":"Drug Resist Updat."},{"key":"4023_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0783-5","volume":"21","author":"J Chua","year":"2019","unstructured":"Chua J, Nafziger E, Leung D. Evidence-based practice: temozolomide beyond glioblastoma. Curr Oncol Rep. 2019;21:30.","journal-title":"Curr Oncol Rep."},{"key":"4023_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneurol.2015.139","volume":"11","author":"M Preusser","year":"2015","unstructured":"Preusser M, Lim M, Hafler DA, Reardon DA, Sampson JH. Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nat Rev Neurol. 2015;11:504\u201314.","journal-title":"Nat Rev Neurol."},{"key":"4023_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2019.01.034","volume":"449","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang K, Jin Y, Sheng X. Endoplasmic reticulum proteostasis control and gastric cancer. Cancer Lett. 2019;449:263\u201371.","journal-title":"Cancer Lett."},{"key":"4023_CR7","doi-asserted-by":"publisher","first-page":"eaal2323","DOI":"10.1126\/scisignal.aal2323","volume":"10","author":"J Obacz","year":"2017","unstructured":"Obacz J, Avril T, Le Reste PJ, Urra H, Quillien V, Hetz C, et al. Endoplasmic reticulum proteostasis in glioblastoma-from molecular mechanisms to therapeutic perspectives. Sci Signal. 2017;10:eaal2323.","journal-title":"Sci Signal."},{"key":"4023_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fonc.2017.00078","volume":"7","author":"M Corazzari","year":"2017","unstructured":"Corazzari M, Gagliardi M, Fimia GM, Piacentini M. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 2017;7:78.","journal-title":"Front Oncol."},{"key":"4023_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.15430\/JCP.2014.19.2.75","volume":"19","author":"RK Yadav","year":"2014","unstructured":"Yadav RK, Chae SW, Kim HR, Chae HJ. Endoplasmic reticulum stress and cancer. J Cancer Prev. 2014;19:75\u201388.","journal-title":"J Cancer Prev."},{"key":"4023_CR10","doi-asserted-by":"publisher","first-page":"104823","DOI":"10.1016\/j.phrs.2020.104823","volume":"157","author":"M Markouli","year":"2020","unstructured":"Markouli M, Strepkos D, Papavassiliou AG, Piperi C. Targeting of endoplasmic reticulum (ER) stress in gliomas. Pharmacol Res. 2020;157:104823.","journal-title":"Pharmacol Res."},{"key":"4023_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2019.04.022","volume":"226","author":"IM Ibrahim","year":"2019","unstructured":"Ibrahim IM, Abdelmalek DH, Elfiky AA. GRP78: a cell\u2019s response to stress. Life Sci. 2019;226:156\u201363.","journal-title":"Life Sci."},{"key":"4023_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69:169\u201381.","journal-title":"Mol Cell."},{"key":"4023_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2016.02.026","volume":"165","author":"F Llambi","year":"2016","unstructured":"Llambi F, Wang YM, Victor B, Yang M, Schneider DM, Gingras S, et al. BOK Is a non-canonical BCL-2 family effector of apoptosis regulated by ER-associated degradation. Cell. 2016;165:421\u201333.","journal-title":"Cell"},{"key":"4023_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5:11.","journal-title":"Signal Transduct Target Ther."},{"key":"4023_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pharmrev.120.000053","volume":"73","author":"SH Barghout","year":"2021","unstructured":"Barghout SH, Schimmer AD. E1 Enzymes as therapeutic targets in cancer. Pharmacol Rev. 2021;73:1\u201356.","journal-title":"Pharmacol Rev."},{"key":"4023_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2015.03.002","volume":"25","author":"MJ Clague","year":"2015","unstructured":"Clague MJ, Heride C, Urbe S. The demographics of the ubiquitin system. Trends Cell Biol. 2015;25:417\u201326.","journal-title":"Trends Cell Biol."},{"key":"4023_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nm.4474","volume":"24","author":"ML Hyer","year":"2018","unstructured":"Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, et al. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med. 2018;24:186\u201393.","journal-title":"Nat Med."},{"key":"4023_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.semcancer.2020.03.008","volume":"67","author":"T Bonacci","year":"2020","unstructured":"Bonacci T, Emanuele MJ. Dissenting degradation: deubiquitinases in cell cycle and cancer. Semin Cancer Biol. 2020;67:145\u201358.","journal-title":"Semin Cancer Biol."},{"key":"4023_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nsmb.2793","volume":"21","author":"JC Christianson","year":"2014","unstructured":"Christianson JC, Ye Y. Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat Struct Mol Biol. 2014;21:325\u201335.","journal-title":"Nat Struct Mol Biol."},{"key":"4023_CR20","doi-asserted-by":"publisher","first-page":"e13094","DOI":"10.1111\/cmi.13094","volume":"21","author":"D Go","year":"2019","unstructured":"Go D, Lee J, Choi JA, Cho SN, Kim SH, Son SH, et al. Reactive oxygen species-mediated endoplasmic reticulum stress response induces apoptosis of Mycobacterium avium-infected macrophages by activating regulated IRE1-dependent decay pathway. Cell Microbiol. 2019;21:e13094.","journal-title":"Cell Microbiol."},{"key":"4023_CR21","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1080\/15548627.2015.1091141","volume":"11","author":"HO Rashid","year":"2015","unstructured":"Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: autophagy induction, inhibition, and selection. Autophagy. 2015;11:1956\u201377.","journal-title":"Autophagy"},{"key":"4023_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016;21:29.","journal-title":"Cell Mol Biol Lett."},{"key":"4023_CR23","doi-asserted-by":"publisher","first-page":"116113","DOI":"10.1016\/j.carbpol.2020.116113","volume":"237","author":"WC Qi","year":"2020","unstructured":"Qi WC, Zhou XT, Wang JQ, Zhang K, Zhou YJ, Chen SP, et al. Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling. Carbohydr Polym. 2020;237:116113.","journal-title":"Carbohydr Polym."},{"key":"4023_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2019.02.052","volume":"451","author":"WY Yang","year":"2019","unstructured":"Yang WY, Jiang CL, Xia WY, Ju HY, Jin SF, Liu SL, et al. Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma. Cancer Lett. 2019;451:34\u201347.","journal-title":"Cancer Lett."},{"key":"4023_CR25","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2019.01.076","volume":"26","author":"M Minata","year":"2019","unstructured":"Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, et al. Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation. Cell Rep. 2019;26:1893\u2013905 e1897.","journal-title":"Cell Rep."},{"key":"4023_CR26","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","volume":"107","author":"EA Obeng","year":"2006","unstructured":"Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr., Lee KP, Boise LH. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907\u201316.","journal-title":"Blood"},{"key":"4023_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcancer.2015.04.003","volume":"33","author":"E Dufey","year":"2015","unstructured":"Dufey E, Urra H, Hetz C. ER proteostasis addiction in cancer biology: novel concepts. Semin Cancer Biol. 2015;33:40\u201347.","journal-title":"Semin Cancer Biol."},{"key":"4023_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2015.03.003","volume":"33","author":"M Maurel","year":"2015","unstructured":"Maurel M, McGrath EP, Mnich K, Healy S, Chevet E, Samali A. Controlling the unfolded protein response-mediated life and death decisions in cancer. Semin Cancer Biol. 2015;33:57\u201366.","journal-title":"Semin Cancer Biol."},{"key":"4023_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/2159-8290.CD-14-1490","volume":"5","author":"E Chevet","year":"2015","unstructured":"Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov. 2015;5:586\u201397.","journal-title":"Cancer Discov."},{"key":"4023_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1182\/bloodadvances.2018026880","volume":"3","author":"S Best","year":"2019","unstructured":"Best S, Hashiguchi T, Kittai A, Bruss N, Paiva C, Okada C, et al. Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells. Blood Adv. 2019;3:51\u201362.","journal-title":"Blood Adv."},{"key":"4023_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41375-018-0167-0","volume":"33","author":"SH Barghout","year":"2019","unstructured":"Barghout SH, Patel PS, Wang XM, Xu GW, Kavanagh S, Halgas O, et al. Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia. Leukemia. 2019;33:37\u201351.","journal-title":"Leukemia"},{"key":"4023_CR32","doi-asserted-by":"publisher","first-page":"100834","DOI":"10.1016\/j.tranon.2020.100834","volume":"13","author":"YJ Liu","year":"2020","unstructured":"Liu YJ, Awadia S, Delaney A, Sitto M, Engelke CG, Patel H, et al. UAE1 inhibition mediates the unfolded protein response, DNA damage an caspase-dependent cell death in pancreatic cancer. Transl Oncol. 2020;13:100834.","journal-title":"Transl Oncol."},{"key":"4023_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/35014014","volume":"2","author":"A Bertolotti","year":"2000","unstructured":"Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol. 2000;2:326\u201332.","journal-title":"Nat Cell Biol."},{"key":"4023_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","volume":"3","author":"J Shen","year":"2002","unstructured":"Shen J, Chen X, Hendershot L, Prywes R. ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals. Dev Cell. 2002;3:99\u2013111.","journal-title":"Dev Cell"},{"key":"4023_CR35","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3892\/ijo.2016.3682","volume":"49","author":"K Hattermann","year":"2016","unstructured":"Hattermann K, Fluh C, Engel D, Mehdorn HM, Synowitz M, Mentlein R, et al. Stem cell markers in glioma progression and recurrence. Int J Oncol. 2016;49:1899\u2013910.","journal-title":"Int J Oncol."},{"key":"4023_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2017.10.017","volume":"184","author":"S Hombach-Klonisch","year":"2018","unstructured":"Hombach-Klonisch S, Mehrpour M, Shojaei S, Harlos C, Pitz M, Hamai A, et al. Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response. Pharmacol Ther. 2018;184:13\u201341.","journal-title":"Pharmacol Ther."},{"key":"4023_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396\u2013401.","journal-title":"Nature"},{"key":"4023_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13046-019-1235-7","volume":"38","author":"X Liu","year":"2019","unstructured":"Liu X, Chen X, Shi L, Shan Q, Cao Q, Yue C, et al. The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma. J Exp Clin Cancer Res. 2019;38:219.","journal-title":"J Exp Clin Cancer Res."},{"key":"4023_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13045-016-0338-2","volume":"9","author":"X Liu","year":"2016","unstructured":"Liu X, Chong Y, Tu Y, Liu N, Yue C, Qi Z, et al. CRM1\/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways. J Hematol Oncol. 2016;9:108.","journal-title":"J Hematol Oncol."}],"updated-by":[{"DOI":"10.1038\/s41419-024-06574-0","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"record-id":"53549"},{"DOI":"10.1038\/s41419-024-06574-0","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04023-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:11:19Z","timestamp":1709928679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04023-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["4023"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04023-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"assertion":[{"value":"27 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-024-06574-0","URL":"https:\/\/doi.org\/10.1038\/s41419-024-06574-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experimental protocol for animal studies was reviewed and approved by ethics committee of Xuzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"733"}}